Institut Bergonié
Clinical trials sponsored by Institut Bergonié, explained in plain language.
-
Lung cancer combo therapy study pulled before start
Disease control TerminatedThis study aimed to test a combination of chemotherapy and radiation for people with advanced non-small cell lung cancer that could not be removed by surgery. The plan included chemotherapy before, during, and after radiation. However, the study was withdrawn before any participa…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New biopsy method could prevent cancer spread during fibroid surgery
Diagnosis OngoingThis study looks at whether a special ultrasound-guided biopsy can accurately tell if a uterine tumor is cancerous before surgery. About 19 women with suspicious uterine tumors will have the biopsy, and the results will be checked against the final diagnosis after surgery. If the…
Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
Why do some women develop chronic pain after breast cancer surgery? study aims to find out
Knowledge-focused TerminatedThis study aimed to understand which psychological and social factors might increase the risk of long-term pain after breast cancer surgery. It planned to follow women undergoing mastectomy or lumpectomy to track their pain levels over time. However, the study was withdrawn befor…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC
-
Can muscle loss predict chemotherapy timing in ovarian cancer?
Knowledge-focused OngoingThis study examines muscle loss (sarcopenia) in 25 women with advanced ovarian cancer who cannot have surgery right away. Researchers will check CT scans taken before chemotherapy to see how common muscle loss is. The goal is to learn if muscle loss affects how quickly patients c…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC